THE IMMUNE RESPONSE AGAINST CANCER IS MODULATED BY STROMAL CELL FIBRONECTIN
Alexander Lubosch, Lauren A. Pitt, Caren Zoeller, Franziska Wirth, Tarik Exner, Barbara A. Steigenberger, Guido H. Wabnitz, Jutta Schröder–Braunstein, Inaam A. Nakchbandi
The paper identifies tumor-inhibitory fibroblasts that produce fibronectin, which activates signaling pathways in neighboring cells to enhance immune response against early cancer.
Neoplasia · Jul 1, 2025Peer-reviewedCancer Biology